Table 1 Demographic data and comparisons between the migraine group and control group
From: CGRP and PACAP-38 play an important role in diagnosing pediatric migraine
Characteristics | Migraine | Control | P-value |
|---|---|---|---|
Number | 76 | 77 | Â |
Age (years) | 10.38 ± 3.73 | 9.46 ± 3.91 | 0.141 |
Gender (male) | 35 (46%) | 47 (61%) | 0.064 |
Clinical Characteristics | |||
 Course (months) | 2.00 ± 8.33 |  |  |
 Duration attacks (hours) | 2.41 ± 2.86 |  |  |
 VAS score | 5.11 ± 2.25 |  |  |
 Frequency (times/month) | 10.00 ± 11.00 |  |  |
 Ictal phase | 43 (57%) |  |  |
 Aura | 32 (42%) |  |  |
 Concomitant symptoms | 55 (72%) |  |  |
Aura | |||
 Visual aura | 19 (25%) |  |  |
 Sensory aura | 12 (16%) |  |  |
 Motor aura | 7 (9%) |  |  |
Concomitant symptoms | |||
 Nausea | 37 (49%) |  |  |
 Vomiting | 24 (32%) |  |  |
 Photophobia | 18 (24%) |  |  |
 Phonophobia | 12 (16%) |  |  |
 Dizziness | 28 (37%) |  |  |
 Ophthalmalgia | 11 (14%) |  |  |
 Abdominal pain | 14 (18%) |  |  |
Pain site | |||
 Unilateral temporal | 21 (28%) |  |  |
 Bilateral temporal | 13 (17%) |  |  |
 Frontal | 28 (37%) |  |  |
 Parietal | 23 (30%) |  |  |
 Occipital | 10 (13%) |  |  |